The US leading drug maker Pfizer Inc. will pay total $60.2 million to settle a federal investigation on alleged bribing overseas doctors and other health officials to prescribe medicines. ­The US Securities and Exchange Commission announced that the company will pay a $45 million fine to resolve charges of bribery in more than a dozen countries in Asia and Eastern Europe. Separately, Pfizer agreed...